Lundbeck

Highly Engaged Employees

Lundbeck is a global pharmaceutical leader specializing in the research, development, and manufacturing of innovative treatments for psychiatric and neurological disorders. Established in 1915, the company maintains a dedicated focus on brain health, addressing complex conditions through advanced clinical trials and biopharmaceutical solutions. By prioritizing patient outcomes and scientific rigor, Lundbeck has solidified its position as a key player in the international healthcare sector, consistently delivering high-quality medical interventions to patients worldwide.

Operating with a workforce of 5,000-10,000 employees, the organization manages a robust operational footprint across 17 global locations. This scale enables the company to maintain high standards of compliance and clinical excellence while driving the development of new therapeutic agents. The firm’s infrastructure supports a wide range of activities, from early-stage research to large-scale manufacturing, ensuring that its medical products reach patients effectively across diverse international markets. This operational capacity is essential for maintaining its competitive edge in the global pharmaceutical landscape.

Lundbeck competes with major industry entities such as UCB, Astellas Pharma, and Biogen, consistently navigating the complex competitive landscape of the pharmaceutical industry. The company’s commitment to scientific advancement is reflected in its diverse product portfolio, which includes specialized treatments for brain-related diseases. Meet Lundbeck's team to learn about the leadership driving these initiatives. Through strategic investment in research and development, the firm continues to address unmet medical needs, reinforcing its status as a cornerstone of modern neurological and psychiatric care. The company remains focused on long-term growth and innovation within the healthcare sector.